Biogen (BIIB) Stock Chart & Stock Price History $135.22 +1.08 (+0.80%) As of 10:13 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Biogen Stock Price Performance The Biogen (BIIB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 40.16%, with a year-to-date return of -11.57%. In the past month, the stock has increased 14.40%, reflecting recent market activity. As of the latest close, Biogen traded at $134.15 with a market cap of $19.66 billion and volume of 1.08 million shares. Five years ago, the stock traded at $295.25, representing a 54.20% decrease over that period. At the time, it had a market cap of $49.16 billion and a volume of 1.37 million shares. Receive BIIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biogen and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.73%1 Month Performance+14.40%3 Month Performance-10.27%Year-To-Date Performance-11.57%1 Year Performance-40.16%5 Year Performance-54.20% BIIB Stock Chart for Tuesday, June, 10, 2025 BIIB Chart by TradingView Biogen Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/09/2025$133.13$134.15+0.77%$135.69$132.931.08 million shs$19.66 billion06/06/2025$130.36$133.13+2.12%$133.72$131.451.17 million shs$19.51 billion06/05/2025$131.86$130.36-1.14%$132.12$129.611.24 million shs$19.10 billion06/04/2025$131.84$131.86+0.02%$133.66$131.671.47 million shs$19.32 billion06/03/2025$131.14$131.84+0.53%$134.74$129.511.82 million shs$19.32 billion06/02/2025$131.11$131.14+0.02%$131.85$128.071.87 million shs$19.22 billion05/30/2025$132.75$131.11-1.24%$132.59$129.623.64 million shs$19.21 billion05/29/2025$127.53$132.75+4.09%$132.94$127.531.96 million shs$19.45 billion05/28/2025$128.39$127.53-0.67%$129.90$126.871.56 million shs$18.69 billion05/27/2025$125.81$128.39+2.05%$129.36$125.891.58 million shs$18.81 billion Get the Latest News and Ratings for BIIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biogen and its competitors with MarketBeat's FREE daily newsletter. 05/26/2025$125.81$125.81$126.19$123.97837,351 shs$18.43 billion05/23/2025$126.30$125.81-0.39%$126.19$123.97837,351 shs$18.43 billion05/22/2025$126.82$126.30-0.41%$127.07$125.35937,000 shs$18.51 billion05/21/2025$130.55$126.82-2.86%$130.07$126.281.59 million shs$18.58 billion05/20/2025$129.44$130.55+0.86%$131.13$128.821.68 million shs$19.13 billion05/19/2025$125.59$129.44+3.07%$129.56$124.932.39 million shs$18.97 billion05/16/2025$123.70$125.59+1.53%$125.77$122.461.80 million shs$18.40 billion05/15/2025$120.37$123.70+2.77%$123.72$119.181.94 million shs$18.13 billion05/14/2025$123.16$120.37-2.27%$123.74$120.041.50 million shs$17.64 billion05/13/2025$124.40$123.16-1.00%$124.40$121.601.72 million shs$18.05 billion05/12/2025$118.20$124.40+5.25%$124.82$119.462.55 million shs$18.23 billion05/09/2025$118.39$118.20-0.16%$120.11$118.051.31 million shs$17.32 billion Related Companies Regeneron Pharmaceuticals Stock Chart Alnylam Pharmaceuticals Stock Chart United Therapeutics Stock Chart Incyte Stock Chart Neurocrine Biosciences Stock Chart Exelixis Stock Chart BioMarin Pharmaceutical Stock Chart Exact Sciences Stock Chart Halozyme Therapeutics Stock Chart Repligen Stock Chart Receive BIIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biogen and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIIB) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.It could very well mark the beginning of a new multitrillion-dollar industrial revolution. Up until now, we...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredElon’s “Secret Mission”Tesla, SpaceX and Starlink made billions for investors... But a meeting Elon had on March 21st, 2025, could...Behind the Markets | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major shift is coming this July — and Wall Street isn't waiting around. Thanks to a new rule going into e...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
